Crombez Eric

CIK 00016530523 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001653052

Recent Transactions

24 trades

Sale
ABEONA THERAPEUTICS INC.$ABEO
Common Stock
2025-08-14$6.93/sh−4,718→ 42,427 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-05-05$39.24/sh−520→ 71,530 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-04-21$35.11/sh−242→ 71,680 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-03$42.10/sh−8,945→ 71,922 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Ooption (Right to Buy)
2025-03-01+30,246→ 30,246 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-01+16,813→ 65,244 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-01+14,971→ 80,215 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Common Stock
2025-01-31+36,101→ 47,145 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Common Stock
2024-08-13+11,044→ 11,044 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-05-02$43.66/sh−354→ 48,431 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-04-18$44.10/sh−142→ 48,785 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01+19,400→ 49,912 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2024-03-01+2,351→ 2,351 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01$53.76/sh−1,238→ 48,927 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2024-03-01+34,200→ 34,200 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2023-09-27+2,351→ 2,351 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-05-01+4,658→ 30,512 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2023-05-01+8,362→ 8,362 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−50,000→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−50,000→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−80,396→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−128,292→ 0 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-02-01+50,000→ 50,000 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2016-02-01+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT

NOVATO, CA, 94949

View on SEC.gov